ESPERITE N.V. convenes Annual General Meeting of Shareholders
Amsterdam, the Netherlands - 27 November 2018
Esperite N.V. (Euronext: ESP, "Esperite") announces that it has convened its Annual General Meeting of Shareholders ("AGM") to be held on 8 January 2019 at 14:00 hours CET at Hotel NH Amsterdam Barbizon Palace, Prins Hendrikkade 59-72, 1012 AD, Amsterdam, The Netherlands.
The AGM's convocation notice, agenda and the explanatory notes to the agenda and further AGM materials can be downloaded from Esperite's website (www.esperite.com) and are available free of charge at Esperite's offices in Amsterdam, The Netherlands.
Shareholders interested in attending the AGM are invited to contact Esperite.
ESPERITE group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and precision medicine founded in 2000.
To learn more about the ESPERITE Group, or to book an interview with CEO Frédéric Amar: +31 575 548 998 - email@example.com or visit the websites at www.esperite.com, www.genoma.com and www.cryo-save.com.
Upcoming Life Sciences Events
- May 2019
- Zurich: The Pharmaceutical Out-licensing Course
- New York: Inhalation & Respiratory Drug Delivery 2019
- June 2019
- Philadelphia, PA: Product and Company Valuation Course